Jupiter Acquisition Corporation

announcedU=S+W/2W=S@11.50
JAQCSEC EDGARCIK: 0001817868|Jupiter Founders LLC•Psychedelic Drug Development

Capital Structure & Economics

Trust Size$150,000,000
Unit Price$10.00
Warrant Coverage1/2
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

50% Warrant Inclusion
Public Trust Allocation$150,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedAug 25, 2020
Target AnnouncedJul 18, 2023
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyFilament Health Corp.
  • SectorPsychedelic Drug Development
  • Announced Deal Size$176,000,000
  • Announcement Date2023-07-18

Board & Officers

  • James N. Hauslein(2)
    CEO
  • James N. ClarkeDirector
  • Gaurav BurmanDirector
  • Jonathan LeongDirector
  • Robert A. KnoxDirector
  • George L. PitaDirector
  • John D. White, Jr.Director
  • James ThayerDirector
  • Louis G. Zachary, Jr.Director
  • John G. ChachasDirector
  • C. Blake SaundersDirector
  • William PateDirector

Advanced Structuring Terms

Target SectorsPsychedelic Drug Development

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction